Carole Ho - Aug 23, 2022 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Chief Medical Officer
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Aug 23, 2022
Transactions value $
-$77,520
Form type
4
Date filed
8/25/2022, 06:10 PM
Previous filing
Aug 23, 2022
Next filing
Sep 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale -$77.5K -2.42K -1.4% $31.98 171K Aug 23, 2022 See footnote F1, F2
holding DNLI Common Stock 25K Aug 23, 2022 See footnote F3
holding DNLI Common Stock 106K Aug 23, 2022 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
F2 The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.
F3 The shares are held of record by the Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.
F4 Includes 105,187 restricted stock units.